RETEVMO 40 mg/1

RETEVMO 40 mg capsules are a prescription medication used to treat certain types of cancer. This oral medication is designed to target specific genetic mutations, offering a targeted approach to cancer therapy.

RETEVMO 40 mg capsules are primarily used in the treatment of advanced or metastatic cancers that harbor specific genetic alterations. These capsules are often prescribed for patients with RET fusion-positive cancers, providing a tailored treatment option for those with these genetic markers. RETEVMO is used to address the underlying genetic drivers of cancer, aiming to slow or halt disease progression.

Common effects of RETEVMO 40 mg capsules may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue, muscle pain, or changes in taste. These effects can vary in severity and duration, and it's important to discuss any persistent or concerning symptoms with a healthcare provider.

RETEVMO 40 mg capsules should be handled with care, following the prescribed dosage and administration instructions. It is essential to inform your healthcare provider about any pre-existing medical conditions or allergies before starting this medication. Pregnant women or those planning to become pregnant should consult their healthcare provider due to potential risks.

RETEVMO 40 mg capsules may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to discuss all current medications, including over-the-counter drugs and supplements, with your healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may affect the efficacy or safety of RETEVMO.